SMTL ID : 7qpj.1

Crystal structure of engineered TCR (756) complexed to HLA-A*02:01 presenting MAGE-A10 9-mer peptide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.54 Å

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x GLY- LEU- TYR- ASP- GLY- MET- GLU- HIS- LEU: Melanoma-associated antigen 10(Non-covalent)

GLY-LEU-TYR-ASP-GLY-MET-GLU-HIS-LEU.1: 46 residues within 4Å: Chain A: M.6, Y.8, F.10, F.34, M.46, Y.60, E.64, K.67, V.68, H.71, T.74, V.77, D.78, T.81, L.82, Y.85, V.96, R.98, Y.100, H.115, Y.117, Y.124, I.125, T.144, K.147, W.148, V.153, Q.156, L.157, Y.160, W.168, Y.172 Chain C: S.32, R.93, G.94, T.95, G.96, R.97, R.98 Chain D: N.31, Y.32, Y.34, V.51, S.95, F.96, A.97 47 PLIP interactions: 33 interactions with chain A, 6 interactions with chain D, 8 interactions with chain C Hydrophobic interactions: A:Y.8, A:F.10, A:K.67, A:V.68, A:L.82, A:Y.100, A:Y.117, A:Y.124, A:T.144, A:W.148, A:V.153, A:Y.160, A:Y.160, D:Y.32, D:F.96 Hydrogen bonds: A:Y.8, A:E.64, A:K.67, A:H.71, A:D.78, A:Y.100, A:Y.100, A:W.148, A:Q.156, A:Y.160, C:R.93, C:R.93, C:G.96, C:R.98 Water bridges: A:Q.73, A:T.74, A:D.78, A:T.81, A:T.81, A:R.98, A:H.115, A:Q.156, A:W.168, D:N.31, D:N.31, D:Y.32, D:V.51, C:S.32, C:R.98 Salt bridges: A:K.147, C:R.93, C:R.98

4 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 6 residues within 4Å: Chain A: T.164, E.167, W.168, R.171 Chain C: R.29, G.30 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.167, A:R.171 Water bridges: A:W.168 GOL.3: 7 residues within 4Å: Chain A: S.5, R.7, F.9, Y.28, D.30, D.31 Chain B: Y.64 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.31 Water bridges: A:D.30 GOL.4: 7 residues within 4Å: Chain A: E.59, D.62, G.63, R.66 Chain C: D.28, T.95, R.97 7 PLIP interactions: 6 interactions with chain A, 1 interactions with chain C Hydrogen bonds: A:E.59, A:E.59, A:E.59, A:D.62, A:G.63, A:R.66, C:D.28 GOL.5: 5 residues within 4Å: Chain A: D.130, L.131, R.132, R.158, E.162 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.132, A:R.132, A:E.162

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Simister, P.C. et al., Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy. J Immunother Cancer (2022)

Release Date

2022-08-03

Peptides

MHC class I antigen: A
Beta-2-microglobulin: B
T-cell receptor alpha chain: C
T-cell receptor beta chain: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

C
A

D
B

MHC class I antigen

Beta-2-microglobulin

T-cell receptor alpha chain

T-cell receptor beta chain

Related Entries With Identical Sequence